Publications by authors named "Eitler J"

NK cells are endowed with tumor killing ability, nevertheless most cancers impair NK cell functionality, and cell-based therapies have limited efficacy in solid tumors. How cancers render NK cell dysfunctional is unclear, and overcoming resistance is an important immune-therapeutic aim. Here, we identify autophagy as a central regulator of NK cell anti-tumor function.

View Article and Find Full Text PDF
Article Synopsis
  • Radiation-induced morphea (RIM) is an uncommon complication of radiotherapy, mainly seen in breast cancer patients, characterized by inflammatory fibrosis where the underlying mechanisms are not well understood.
  • The study focused on analyzing fibroblasts from RIM patients to find potential therapeutic targets, discovering key differences like increased alpha-smooth-muscle-actin (αSMA) and Myc activation in RIM fibroblasts.
  • Treatment with the anti-inflammatory drug mesalazine was shown to effectively improve patient symptoms by reversing the harmful fibroblast changes and significantly reducing levels of the biomarker osteopontin (OPN).
View Article and Find Full Text PDF
Article Synopsis
  • NK cells can be made more effective against tumors through targeting with antibodies or genetic modifications, but some tumors still resist attacks, particularly in the context of the ErbB2 (HER2) antibody trastuzumab.
  • In experiments, using NK-92 cells and primary human NK cells, functions like cell killing and cytokine release were diminished when LFA-1 was blocked or ICAM-1 was absent during ADCC triggered by trastuzumab, but CAR-engineered NK cells showed resilience against these disruptions.
  • The study found that while trastuzumab needed LFA-1 to fully activate NK cells, the ErbB2-CAR provided a strong activation on its own, leading to effective tumor targeting, and
View Article and Find Full Text PDF

Natural killer (NK) cells are attractive effectors for adoptive immunotherapy of cancer. Results from first-in-human studies using chimeric antigen receptor (CAR)-engineered primary NK cells and NK-92 cells are encouraging in terms of efficacy and safety. In order to further improve treatment strategies and to test the efficacy of CAR-NK cells in a personalized manner, preclinical screening assays using patient-derived tumor samples are needed.

View Article and Find Full Text PDF

Introduction: Natural killer 92 (NK-92) cells are an attractive therapeutic approach as alternative chimeric antigen receptor (CAR) carriers, different from T cells, once they can be used in the allogeneic setting. The modest outcomes observed with NK-92 cells continue to present hurdles in successfully translating NK-92 cell therapies into clinical applications. Adoptive transfer of CAR-NK-92 cells holds out the promise of therapeutic benefit at a lower rate of adverse events due to the absence of GvHD and cytokine release syndrome.

View Article and Find Full Text PDF

The immunological synapse (IS) between NK cells and cancer cells is instrumental for the initiation of tumor-specific cytotoxicity. Improper function of processes at the IS can lead to NK cell unresponsiveness, contributing to tumor immune escape. Critical steps at the IS include target cell recognition, conjugation of NK cell and cancer cell, cytotoxic granule convergence to the microtubule-organizing center (MTOC), granule polarization to the IS, and degranulation.

View Article and Find Full Text PDF

Background: On encountering a susceptible target, natural killer (NK) cells mediate cytotoxicity through highly regulated steps of directed degranulation. Cytotoxic granules converge at the microtubule organizing center and are polarized toward the immunological synapse (IS), followed by granule exocytosis. NK cell retargeting by chimeric antigen receptors (CARs) or mAbs represents a promising strategy for overcoming tumor cell resistance.

View Article and Find Full Text PDF

Antigen-specific redirection of immune effector cells with chimeric antigen receptors (CARs) demonstrated high therapeutic potential for targeting cancers of different origins. Beside CAR-T cells, natural killer (NK) cells represent promising alternative effectors that can be combined with CAR technology. Unlike T cells, primary NK cells and the NK cell line NK-92 can be applied as allogeneic off-the-shelf products with a reduced risk of toxicities.

View Article and Find Full Text PDF

Osteoclasts are multinucleated giant cells that resorb bone, ensuring development and continuous remodelling of the skeleton and the bone marrow haematopoietic niche. Defective osteoclast activity leads to osteopetrosis and bone marrow failure, whereas excess activity can contribute to bone loss and osteoporosis. Osteopetrosis can be partially treated by bone marrow transplantation in humans and mice, consistent with a haematopoietic origin of osteoclasts and studies that suggest that they develop by fusion of monocytic precursors derived from haematopoietic stem cells in the presence of CSF1 and RANK ligand.

View Article and Find Full Text PDF

Regulatory mechanisms controlling the pool size of spleen dendritic cells (DC) remain incompletely understood. DCs are continuously replenished from hematopoietic stem cells, and FLT3-mediated signals cell-intrinsically regulate homeostatic expansion of spleen DCs. Here we show that combining FLT3 and CSF1R-deficiencies results in specific and complete abrogation of spleen DCs in vivo.

View Article and Find Full Text PDF

Even though the earliest prosthetic devices date to the Ancient Egyptian Empire and iconographic sources attest their use in the Greco-Roman world, archaeological evidence for this practice prior to 2nd millennium AD is very scant. In 2013, a skeleton dating to the Frankish period (6th century AD) was excavated at the Hemmaberg in southern Austria. The middle adult male was missing his left foot from above the ankle.

View Article and Find Full Text PDF

Background: Quantitative real-time PCR (qPCR) is becoming increasingly important for DNA genotyping and gene expression analysis. For continuous monitoring of the production of PCR amplicons DNA-intercalating dyes are widely used. Recently, we have introduced a new qPCR mix which showed improved amplification of medium-size genomic DNA fragments in the presence of DNA dye SYBR green I (SGI).

View Article and Find Full Text PDF